Clinical Trials Directory

Trials / Unknown

UnknownNCT01293474

Choroidal Thickness in Glaucoma Patients and Healthy Controls

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

With the new software tool (EDI, enhanced depth imaging) of the Spectralis® spectral-domain optical coherence tomography (SD-OCT) it is possible to visualize and measure the choroidal thickness. In glaucoma a vascular component is known. Therefore a difference of choroidal thickness in glaucoma patients and healthy controls is proposed. * Trial with medical device

Conditions

Interventions

TypeNameDescription
DEVICESpectralis® SD-OCT, Heidelberg Engineering GmbH, HMeasurement of the choroidal thickness with Spectralis® SD-OCT

Timeline

Start date
2011-02-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-02-10
Last updated
2015-01-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01293474. Inclusion in this directory is not an endorsement.